Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Ollin eyes phase 3 after topping Vabysmo in early-stage trial
Given the findings, the Texas-based biotech is now planning to launch global phase 3 studies this year.
Gabrielle Masson
Jan 8, 2026 3:20pm
Longtime Charles River CEO to retire; COO will take the helm
Jan 8, 2026 12:54pm
Sponsored
Teverelix: A New Direction in Prostate Cancer and Urologic Health
Jan 5, 2026 8:00am
Quest, Labcorp add fully at-home STI test to women’s health offerings
Jan 8, 2026 11:08am
Fierce Biotech Layoff Tracker 2026
Jan 8, 2026 11:00am
Fierce Biotech Fundraising Tracker 2026
Jan 8, 2026 10:45am
More News
GSK inks model deal in $50M bet on Noetik's cancer AI platform
Jan 8, 2026 10:30am
Flagship-founded Tessera plans to lay off 90 employees in March
Jan 8, 2026 10:00am
Lexeo, J&J team up on heart pump tech for gene therapy delivery
Jan 8, 2026 9:30am
J&J, Google venture arms line up to back EpiBiologics' series B
Jan 8, 2026 9:05am
See more stories
